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Abstract 
The genetic component of athletic performance approximates 50%, depending on which specific element of performance is 
considered.  Limited genetic testing is already available commercially and genetic tests are likely to become powerful tools to 
improve sport performance in the future. Currently, however, selection of athletes for training squads or competition based on 
genomic data is premature. Larger volumes of longitudinal data within individual sports are needed to determine the efficacy of using 
genomic data in the management of elite athletes via manipulation of training load and diet based on personal genomic information. 
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Since the 1990s, exercise genomics research has regularly 
involved investigation of DNA sequence variation in relation to 
exercise-related phenotypes.  Although the pace of this 
research remains modest, progress is being made and 
significant advances are predicted for the near future (Pitsiladis 
et al., 2013). 
The difference between success and failure in competitive sport 
is often determined by extremely small performance margins 
(Pyne et al., 2004) that can be influenced by physiology, 
genetics, psychological factors, etc.  Just one of many possible 
examples is the 0.01 s margin of victory for Michael Phelps 
during the 100 m butterfly at the 2008 Olympic Games.  There 
are numerous accounts of scientists, coaches and athletes 
adopting (or at least trialling, in a practical setting) innovative, 
permitted strategies in an attempt to improve performance. A    
1% (or even 0.1%) improvement in performance could be the 
difference between winning and losing and the drive to improve 
performance by even those tiny fractions can be all-consuming 
for those people involved.  Yet the consequences of failure to 
improve performance do not threaten health - even adverse 
responses rarely pose a risk to life or have serious health 
consequences.  Therefore, it is arguable that the standard of 
evidence required before practical trials begin by athletes and 
coaches is lower than that required for newly-developed cancer 
drugs in a clinical setting, for example.  Nevertheless, 
responsible scientists should act and base recommendations on 
evidence. 
In exercise genomics, our impression from speaking with 
colleagues at international conferences and similar events, is 
that the scientific consensus appears to be that practical 
application to sport at this time is probably premature – and this 
impression is despite the standard of evidence comments we 
make above. Certainly, in terms of athlete selection for 
competition or training squads, more research is required before 
existing practices in sport could justifiably be changed due to 
genomic data.  Firstly, researchers must recruit larger numbers 
of athletes for case-control study designs (Bouchard, 2011; 
Pitsiladis et al., 2013) and identify more genetic variants that 
contribute to the genetic component of sport performance.  We 
are aware of major efforts in this regard involving athletes of 
recent African ancestry and other efforts taking place in eastern 
Europe (Russia and neighbouring countries), China, Australia, 
Brazil, Japan and the UK (UK athletes are a current focus of our 
own work), while several other research groups are making 
similar efforts.  Thus, international collaboration seems logical to 
pool data and resources where feasible and appropriate.  
Secondly, researchers must conduct comprehensive research 
within a given sport. Grouping different sports (and even 
different specialities within a sport) to boost sample size 
theoretically brings important increases in statistical power but 
also other difficulties by diluting the phenotypic characteristics, 
selection and training practices of elite athlete groups.   
Conducting comprehensive genomics research within a given 
sport would limit the problem of diluting phenotypic 
characteristics, selection and training practices, and requires co-
operation from relevant stakeholders within at least one 
reasonably large nation (and preferably internationally), as well 
as careful consideration of the recent geographic ancestry of the 
athletes. The net effect of purifying the sport phenotype versus 
limiting sample size, both of which affect statistical power but in 
opposite directions, is unclear at this time. However, if a large 
sample size can be obtained where the phenotypes, selection 
and training practices are precisely defined and consistent, we 
believe that powerful, convincing data will ultimately be 
produced that influence the management of elite athletes.  We 
have enticing, unpublished, preliminary genomic data from 
within the sport of rugby union that addresses some of these 
issues.  We of course envisage genomic information 
complementing the existing phenotypic data collected and used 
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by sports coaches and supporting exercise scientists – genomic 
information will never be a replacement for such data, but an 
additional tool. 
We predict the first evidence-based practical application of 
genomic information in the management of elite athletes will 
involve modification of training in an attempt to reduce the 
likelihood of injury when an athlete is predicted from his or her 
genome to be at higher than average risk.  Secondly, 
personalisation of training programmes should become possible       
in sports where two or more physiological characteristics 
combine to produce athletic performance.  For example, in 
many team sports where a combination of endurance and sprint 
ability are required, at a truly elite level (where physiological 
monitoring and strength and conditioning support are of the 
highest standard) it should become possible to carefully modify 
the relative emphasis during training of the development of 
those two physiological characteristics according to athlete 
genotype.  Thirdly, and probably more distantly in the future, 
some selection processes in sport might become informed by 
genomic information, although even in those cases the genomic 
information will always be secondary to the more informative 
phenotypic information. 
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